ambamustine has been researched along with Lymphoma, Non-Hodgkin in 3 studies
*Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellesi, G; Castoldi, G; Gherlinzoni, F; Lanza, F; Mangoni, L; Mazza, P; Rizzoli, V; Rossi Ferrini, PL; Tura, S; Zinzani, PL | 1 |
| Cavo, M; Galieni, P; Gherlinzoni, F; Lemoli, RM; Mazza, P; Poletti, G; Tassi, C; Tura, S; Visani, G; Zinzani, PL | 1 |
3 other study(ies) available for ambamustine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Ambamustine. PTT119.
Topics: Alkylating Agents; Animals; Carcinoma, Small Cell; Drugs, Investigational; Humans; Injections, Intravenous; Italy; Lymphoma, Non-Hodgkin; Mice; Nitrogen Mustard Compounds; Rhabdomyosarcoma | 2003 |
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Thrombocytopenia | 1990 |
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Agents; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrogen Mustard Compounds | 1989 |